Evidence map›Paper›PMID 28240317›Full record

ArticleScientific reports2017

Non-invasive MRI biomarkers for the early assessment of iron overload in a humanized mouse model of β-thalassemia.

Laurence H Jackson, Evangelia Vlachodimitropoulou, Panicos Shangaris, Thomas A Roberts, Thomas M Ryan, Adrienne E Campbell-Washburn, Anna L David, John B Porter, Mark F Lythgoe, Daniel J Stuckey

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. QuantitativeMagma (New York, N.Y.) · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Emerging Therapies.Hematology/oncology clinics of North America · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Laurence H JacksonCentre for Advanced Biomedical Imaging, Division of Medicine, University College London, London, UK.
Evangelia VlachodimitropoulouDepartment of Haematology, University College London, London, UK.
Panicos ShangarisInstitute for Women's Health, University College London, London, UK.
Thomas A RobertsCentre for Advanced Biomedical Imaging, Division of Medicine, University College London, London, UK.
Thomas M RyanDepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Adrienne E Campbell-WashburnLaboratory of Imaging Technology, Biochemistry and Biophysics Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda MD, USA.
Anna L DavidInstitute for Women's Health, University College London, London, UK.
John B PorterDepartment of Haematology, University College London, London, UK.
Mark F LythgoeCentre for Advanced Biomedical Imaging, Division of Medicine, University College London, London, UK.
Daniel J StuckeyCentre for Advanced Biomedical Imaging, Division of Medicine, University College London, London, UK.
University College London · GBLondon Women's Clinic · GBNational Heart Lung and Blood Institute · USUniversity of Alabama at Birmingham · US

Funding

Cell Therapies for Cooley's AnemiaR01HL072351 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RYAN, THOMAS M · 2003 to 2013
$3.4M
ENU Mutagenesis of Gamma Globin Silencers in Sickle MiceR01HL073440 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RYAN, THOMAS M · 2003 to 2006
$1.2M
Cell Therapies for Cooley's AnemiaR56HL072351 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RYAN, THOMAS M · 2014 to 2014
$695k
British Heart Foundation FS/15/33/31608Medical Research Council MR/J013110/1Medical Research Council MR/K026739/1Medical Research Council MR/K50077X/1NHLBI NIH HHS R01 HL072351NHLBI NIH HHS R01 HL073440NHLBI NIH HHS R56 HL072351Wellcome Trust
6 · The paper itself

Abstract

β-thalassemia (βT) is a genetic blood disorder causing profound and life threatening anemia. Current clinical management of βT is a lifelong dependence on regular blood transfusions, a consequence of which is systemic iron overload leading to acute heart failure. Recent developments in gene and chelation therapy give hope of better prognosis for patients, but successful translation to clinical practice is hindered by the lack of thorough preclinical testing using representative animal models and clinically relevant quantitative biomarkers. Here we demonstrate a quantitative and non-invasive preclinical Magnetic Resonance Imaging (MRI) platform for the assessment of βT in the γβ

Indexed as

Animalsbeta-ThalassemiaCardiomyopathiesDisease Models, AnimalFemaleHeartHumansIronIron OverloadLiverMagnetic Resonance ImagingMaleMiceMice, TransgenicSpleenSplenomegalyIron

Identifiers

PMID28240317
PMCPMC5327494
OpenAlexW2592747668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.